Physician profile
Paramvir Singh
NPI 1346213444
$8,109.63
in general payments reported to CMS, 2019-2025
17 companies · $240 in 2025
The $240 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,872 · 2020: $493 · 2021: $124 · 2022: $216 · 2023: $62.20 · 2024: $103 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $6,034.10 | 2019 | |
| Abbvie INC. | $536.50 | 2019-2025 | Creon, Linzess |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $399.16 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $268.38 | 2019-2021 | |
| Madrigal Pharmaceuticals | $215.80 | 2025 | Rezdiffra |
| Allergan, INC. | $205.11 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $118.06 | 2020-2021 | |
| Qol Medical, LLC | $77.56 | 2019-2020 | |
| Boston Scientific Corporation | $61.97 | 2022-2024 | Orcapod |
| Lilly USA, LLC | $41.58 | 2023-2024 | Omvoh |
| Ironwood Pharmaceuticals, INC | $40.80 | 2020 | |
| Nestle Healthcare Nutrition INC. | $21.10 | 2021 | |
| Alfasigma USA, INC. | $20.41 | 2020 | |
| Aimmune Therapeutics, INC. | $19.19 | 2024 | |
| Janssen Biotech, INC. | $17.87 | 2023 | Stelara |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.42 | 2019 | |
| Ethicon US, LLC | $14.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paramvir Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.